CTIS.eu › Cities › Netherlands › Nijmegen
Nijmegen
Netherlands
568 total trials
261 recruiting
2022-500745-24-00
10
2022-09-20
Salivary Duct Carcinoma
2024-515528-35-00
11
2022-09-08
Congenital Haemophilia A
2023-503335-18-00
1
2022-07-29
Chronic myeloid leukemia
2023-504660-41-00
4
2022-07-11
Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (PBC
2024-513924-41-01
6
2022-05-11
Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).
2023-505220-57-03
5
2022-05-09
Predicted severe acute pancreatitis
2023-509743-27-00
4
2022-04-29
Systemic sclerosis associated with interstitial lung disease
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
2024-513797-22-00
5
2022-03-09
HER2 positive esophageal adenocarcinoma
2023-510353-42-00
7
2022-02-21
Myotonic Dystrophy Type 1
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
2023-505497-14-00
4
2021-12-09
Proteinuric glomerular diseases including:
•Focal segmental glomerulo
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
2023-507230-24-00
4
2021-02-17
Cervical cancer
2024-514010-12-00
1
2020-12-03
Advanced Malignancies
2023-508722-99-00
4
2020-11-19
Vulvar cancer
2024-510783-23-00
7
2020-10-29
Fallopian Tube Cancer
2024-512526-28-00
5
2020-10-28
Locally recurrent rectal cancer
2024-515625-29-00
5
2020-06-16
Apnea of prematurity
2023-509343-27-00
11
2019-10-28
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative g
2024-510768-21-00
4
2019-10-16
Rectal cancer
2023-504201-36-00
10
2018-12-21
Defined by parent protocol. The study will enroll all adult and paedia
2022-501254-10-00
5
2018-08-24
Advanced tumors
2024-513627-16-01
7
2018-03-28
Colorectal cancer metastatic
Showing 289–312 of 568 trials